Promising new cocktail targets Hard-to-Treat bile duct cancer
NCT ID NCT07432568
First seen Feb 28, 2026 · Last updated Apr 30, 2026 · Updated 15 times
Summary
This study tests a new combination of drugs for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that cannot be removed by surgery. The treatment includes chemotherapy delivered directly to the liver, an oral targeted therapy, and an immunotherapy drug. The goal is to see if this combination can shrink or eliminate tumors in 30 participants who have not received prior systemic therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.